- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Bone mineral density (BMD)
- Meeting Date: July 2006
- Public Summary Document (PSD) July 2006 PBAC Meeting - PDF
Risedronate sodium; risedronate sodium and calcium carbonate – July 2006
Risedronate Sodium, tablets, 5 mg and 35 mg, Actonel®, Risedronate Sodium And Calcium Carbonate, tablets, 35 mg and 1.25 g, Actonel Combi®, July 2006
Last updated
27 October 2006